Mr. Aras Azadian reports

AVICANNA IS PLEASED TO ANNOUNCE THE INITIAL NETWORK OF BRANDS ON THE MYMEDI.CA PLATFORM

Avicanna Inc. has released its initial portfolio offering and network in anticipation of the MyMedi.ca platform's launch in early August.

In line with the company's commitment to provide continuity of care to Canadian patients serviced by Medical Cannabis by Shoppers and to make available a new cannabis care platform that will offer patients a broad and diverse portfolio of products, the company is pleased to announce the initial network of brands available on MyMedi.ca.

"We are pleased by the level of commitment towards patients that we have seen and the concrete support of this distinct group of Canadian licensed producers that have worked towards the timely launch of the new cannabis care platform, MyMedi.ca. We look forward to continuing to work collaboratively towards the goals of establishing MyMedi.ca as a leading cannabis care platform and towards taking steps to enhance the patient journey," stated Aras Azadian, chief executive officer of Avicanna.

The featured brands that will be available for purchase on MyMedi.ca include the attached list, with more to come.

About Avicanna Inc.

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including research and development and clinical development that has led to the commercialization of more than 30 products across various market segments.

We seek Safe Harbor.